Vaxcyte (PCVX) Stock Highlights

86.53 | +0.37%

2024-12-21 00:56:24

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firms product candidate consists of VAX-24, VAX-XP, VAX-A1, and VAX-PG.

Statistics

Range Today

86.25 88.88

Volume Today 3.29M

Range 1 Year

53.83 121.06

Volume 1 Year 227.92M

Range 3 Year

16.78 121.06

Volume 3 Year 551.94M

Range 10 Year

15.51 121.06

Volume 10 Year 649.69M

Highlights

Market Capitalization 10.78B (large)

Floating Shares 115.47M

Current Price 86.53

Price To Earnings -18.79

Price To Book 3.15

Earnings Per Share -4.6

Payout Ratio 0%

Performance

Latest +0.37%

1 Month -0.38%

3 Months -26.55%

6 Months +20.38%

1 Year +41.71%

3 Years +299.31%

5 Years +316.01%

10 Years +316.01%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.